Patricia Gauthier, the head of Moderna Canada, said are still in negotiations with the federal government about the plant, though they’re making progress.
In the fight against long COVID—only just begun—Canada needs to be at the forefront of researching the causes for these lingering problems and not just hammering away at the symptoms.
Scientists found that the odds of replicating results of 50 preclinical experiments from 23 high-profile published studies were no better than a coin toss.
